Gabapentin vs Vyepti
A side-by-side look at two neurology medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Gabapentin | US Vyepti |
|---|---|---|
| Generic name | gabapentin Unverified catalogue summary (Generic name) for Gabapentin in US; not checked against current local product information. | eptinezumab-jjmr Unverified catalogue summary (Generic name) for Vyepti in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Gabapentin in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Vyepti in US; not checked against current local product information. |
| Treats | Adult postherpetic neuralgia; partial-onset seizures (add-on, age 3+) Unverified catalogue summary (Treats) for Gabapentin in US; not checked against current local product information. | Migraine prevention Unverified catalogue summary (Treats) for Vyepti in US; not checked against current local product information. |
| Category | Neurology Unverified catalogue summary (Category) for Gabapentin in US; not checked against current local product information. | Neurology Unverified catalogue summary (Category) for Vyepti in US; not checked against current local product information. |
| Manufacturer | Various (generic) Unverified catalogue summary (Manufacturer) for Gabapentin in US; not checked against current local product information. | Lundbeck Unverified catalogue summary (Manufacturer) for Vyepti in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Gabapentin in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Vyepti in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Gabapentin in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Vyepti in US; not checked against current local product information. |
| Est. TV ad spend | $1M | — |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Gabapentin in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Vyepti in US; not checked against current local product information. |
Gabapentin
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Gabapentin or Vyepti better?
This directory does not compare clinical effectiveness or safety. Listing Gabapentin and Vyepti together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Gabapentin and Vyepti?
The table shows catalogue identification and estimated advertising information for Gabapentin and Vyepti, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Gabapentin has the larger estimated TV advertising budget of the two.